Product Information
BUSPIRONE HCL 15 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0423 per EA under NDC 68382018205. Its NADAC has been published 611 times since Oct 15, 2014.
Strength
15 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382018205
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078888On Market Since
5/3/2014
Price Statistics
The NADAC for BUSPIRONE HCL 15 MG TABLET has been published 611 times since Oct 15, 2014, and over the history we have for it it has declined 56.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0423 per EA |
|---|---|
| All-time high | $0.1018 (Dec 10, 2014) |
| All-time low | $0.0359 (Nov 20, 2024) |
| 52-week high | $0.0485 |
| 52-week low | $0.0423 |
| Median price | $0.0600 |
| Average price | $0.0634 |
| Largest weekly change | -29.4% (Nov 20, 2024) |
| Weeks tracked | 611 |
| Tracking since | Oct 15, 2014 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 15 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0423 per EA (NDC 68382018205), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 15 MG TABLET has declined 56.4%. It has been tracked across 611 weekly CMS publications since Oct 15, 2014.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 15 MG TABLET?
Since Oct 15, 2014, the NADAC for BUSPIRONE HCL 15 MG TABLET has ranged from a low of $0.0359 (Nov 20, 2024) to a high of $0.1018 (Dec 10, 2014), with a median of $0.0600 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 15 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as BUSPIRONE HCL 15 MG TABLET, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 15 MG TABLET?
BUSPIRONE HCL 15 MG TABLET (NDC 68382018205) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification